XTX Topco Ltd Makes New Investment in Clover Health Investments, Corp. (NASDAQ:CLOV)

XTX Topco Ltd purchased a new stake in shares of Clover Health Investments, Corp. (NASDAQ:CLOVFree Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 757,689 shares of the company’s stock, valued at approximately $932,000. XTX Topco Ltd owned about 0.15% of Clover Health Investments at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CLOV. Jump Financial LLC acquired a new position in shares of Clover Health Investments during the fourth quarter valued at $125,000. SignalPoint Asset Management LLC raised its position in shares of Clover Health Investments by 40.3% during the 1st quarter. SignalPoint Asset Management LLC now owns 139,366 shares of the company’s stock worth $111,000 after buying an additional 40,000 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Clover Health Investments by 151.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 77,948 shares of the company’s stock worth $62,000 after acquiring an additional 46,912 shares during the period. Jupiter Asset Management Ltd. boosted its holdings in shares of Clover Health Investments by 18.1% in the first quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock valued at $3,593,000 after acquiring an additional 692,878 shares in the last quarter. Finally, Bayesian Capital Management LP acquired a new position in shares of Clover Health Investments during the first quarter valued at approximately $142,000. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Clover Health Investments Price Performance

CLOV opened at $2.91 on Friday. The business has a 50 day moving average price of $2.40 and a two-hundred day moving average price of $1.44. The company has a market capitalization of $1.44 billion, a price-to-earnings ratio of -8.56 and a beta of 2.13. Clover Health Investments, Corp. has a 1-year low of $0.61 and a 1-year high of $3.82.

Clover Health Investments (NASDAQ:CLOVGet Free Report) last announced its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.05. The business had revenue of $356.26 million during the quarter, compared to analyst estimates of $338.70 million. Clover Health Investments had a negative return on equity of 36.55% and a negative net margin of 7.30%. During the same quarter in the prior year, the firm posted ($0.06) earnings per share. Equities analysts expect that Clover Health Investments, Corp. will post -0.13 EPS for the current fiscal year.

Clover Health Investments Profile

(Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Featured Stories

Want to see what other hedge funds are holding CLOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clover Health Investments, Corp. (NASDAQ:CLOVFree Report).

Institutional Ownership by Quarter for Clover Health Investments (NASDAQ:CLOV)

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.